In castration-resistant prostate cancer cells, CBP and p300 up-regulate androgen receptor signaling by binding to androgen receptor-binding sites at target gene promoters, activate the transcription of oncogenes such as MYC, and induce cancer cell proliferation 67 (Table 1). This evidence concerns the gene CREBBP and prostate carcinoma.